skip to content

Partnering with Patients

Everything we do for patients, we do with patients as partners every step of the way

Patients are at the core of what we do. We define patient communities broadly to encompass all who are integral to the patient which includes patient groups, patient organisations, patient advocacy groups, expert patients, individual patients, caregivers and family members of patients. This is why we partner with them at each stage of drug development and care delivery.

The role of patient groups is continuously evolving, and they are now more equipped than ever to define healthcare in their own terms. Patients are becoming increasingly involved in their treatment and care choices based on their own unique experiences.

Partnering with patients to further understand their everyday lives is essential to evolve the way we look at diseases. It is through collaboration that we can truly personalise healthcare, taking new approaches to develop better medicines for and with the people that matter most.

[Potrait]

“Patient organisations have provided me with the most insight into the true value of our work.”

Severin Schwan

CEO

The International Experience Exchange with Patient Organisations

At Roche, we believe that by working closely together with the patient community we can make even more of a difference for patients. Our commitment to patient-inclusivity as a company unites us around a strong sense of purpose to put patients first at the heart of healthcare.

International Experience Exchange with Patient Organisations (IEEPO) is a truly patient-led community with over 1000 patient group representatives determined to achieve this purpose. It strives for patient communities to take a seat at the table with all stakeholders and have an equal voice in the healthcare ecosystem and in the decision-making. IEEPO offers a unique opportunity to come together as a community to exchange experiences, find inspiration, and leave with practical, meaningful, and actionable ideas to improve the lives of patients and their families.

Learn more about IEEPO

More stories of partnering with patients

Three women seated at a table, engaged in discussion with papers and pens in front of them.

Elevating the patient voice in Huntington’s disease

How patient partnership is shaping the future of research and clinical development for Huntington’s disease.

A woman sitting in a chair with her arms crossed, displaying a thoughtful expression.

What patients in clinical trials should know about their data

Patients can be at risk of sharing too much, especially in Rare diseases. How can patient advocates support innovation but also defend patient privacy?

[Potrait]

Pandemic-proof patient advocacy

How COVID-19 has changed the world of a patient leader. When work involves advocating for diseases other than COVID-19, the pandemic presents an additional barrier to overcome.

Downloads

Roche Position on Collaborating with Patient Groups and Patients

PDF

Discover more

Working with Patient OrganisationsAbout Roche

Patient organisations are increasingly important partners for Roche. We share an interest in helping patients understand and manage their disease.

Clinical trialsInnovation

Clinical trials are essential to determine whether new drugs or diagnostics are safe and effective when used to diagnose or treat people.

Code of conductAbout Roche

The Roche Group Code of Conduct states the expectations Roche as an employer has towards his employees and sets forth the standards for business behaviour that apply throughout the Roche Group.

ForPatients-

ForPatients is an informational resource for patients, caregivers or doctors looking for information in clear language about clinical trials or diseases where Roche is conducting or supporting research.